However, recent studies have demonstrated that the mTOR blockade has surprising immunostimulatory effects by enhancing the generation of memory precursor effector cells that survive and differentiate into long-lived CD8+ memory cells, allowing better clearance of tumor cells (81). This evidence concerns the gene CD8A and neoplasm.